Share This Article:

Variables Associated with Cirrhosis Diagnosis in Patients with Chronic Hepatitis C: A Case-Control Study

Abstract Full-Text HTML XML Download Download as PDF (Size:302KB) PP. 1634-1641
DOI: 10.4236/health.2015.712176    3,563 Downloads   4,023 Views  

ABSTRACT

The diagnosis of liver cirrhosis in patients with chronic hepatitis C has not always been easy, since the gold standard method is the liver biopsy, which is an invasive procedure with interobserver accuracy problems and there have been reports of complications including records of deaths due to hemoperitoneum. Cirrhosis changes the prognosis of the subject with hepatitis C and requires a different clinical management. This study aimed to identify clinical and laboratory variables associated with the diagnosis of cirrhosis in the ultrasonography of patients infected with hepatitis C. In a case-control study, we evaluated 70 cirrhotic patients with chronic hepatitis C compared to a control group of 70 non-cirrhotic people with positive HCV. The results showed, through logistic regression analysis, that the variables blood donor and professional athlete, adjusted for alcohol consumption, showed OR 0.24 and 0.18, with p values of 0.044 and 0.035, respectively. We conclude that the diagnosis of cirrhosis in patients with chronic hepatitis C remains challenging, but the patients with the condition of blood donor or professional athlete prove to be less likely to cirrhosis in ultrasonography in the initial consultation.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

de Sousa, G. , do Céu Clara Costa, I. , de Souza, D. , de Andrade, F. , Celani, L. , Pessoa, R. , de Souza Filho, M. , de Oliveira, D. , de Medeiros, L. , de Oliveira, L. and Monteiro, M. (2015) Variables Associated with Cirrhosis Diagnosis in Patients with Chronic Hepatitis C: A Case-Control Study. Health, 7, 1634-1641. doi: 10.4236/health.2015.712176.

References

[1] Thein, H.H., Yi, Q., Dore, G.J. and Krahn, M.D. (2008) Estimation of Stage-Specific Fibrosis Progression Rates in Chronic Hepatitis C Virus Infection: A Meta-Analysis and Meta-Regression. Hepatology, 48, 418-431.
http://dx.doi.org/10.1002/hep.22375
[2] Tong, M.J., el-Farra, N.S., Reikes, A.R. and Co, R.L. (1995) Clinical Outcomes after Transfusion Associated Hepatitis C. The New England Journal of Medicine, 332, 1463-1466.
http://dx.doi.org/10.1056/NEJM199506013322202
[3] Niederau, C., Lange, S., Heintges, T., Erhardt, A., Buschkamp, M., Hürter, D., Nawrocki, M., Kruska, L., Hensel, F., Petry, W. and Huussinger, D. (1998) Prognosis of Chronic Hepatitis C: Results of a Large, Prospective Cohort Study. Hepatology, 28, 1687-1695.
http://dx.doi.org/10.1002/hep.510280632
[4] D’Amico, G., Garcia-Tsao, G. and Pagliaro, L. (2006) Natural History and Prognostic Indicators of Survival in Cirrhosis: A Systematic Review of 118 Studies. Journal of Hepatology, 44, 217-231.
http://dx.doi.org/10.1016/j.jhep.2005.10.013
[5] Morgan, R.L., Baack, B., Smith, B.D., Yartel, A., Pitasi, M. and Falck-Ytter, Y. (2013) Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies. Annals of Internal Medicine, 158, 329-337.
http://dx.doi.org/10.7326/0003-4819-158-5-201303050-00005
[6] Morgan, T.R., Ghany, M.G., Kim, H.Y., Snow, K.K., Shiffman, M.L., De Santo, J.L., et al. (2010) Outcome of Sustained Virological Responders with Histologically Advanced Chronic Hepatitis C. Hepatology, 52, 833-844.
http://dx.doi.org/10.1002/hep.23744
[7] Poynard, T., Bedossa, P. and Opolon, P. (1997) Natural History of Liver Fibrosis Progression in Patients with Chronic Hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC Groups. The Lancet, 349, 825-832.
[8] Poynard, T., Munteanu, M., Imbert-Bismut, F., Charlotte, F., Thabut, D., Le Calvez, S., Messous, D., Thibault, V., Benhamou, Y., Moussalli, J. and Ratziu, V. (2004) Prospective Analysis of Discordant Results between Biochemical Markers and Biopsy in Patients with Chronic Hepatitis C. Clinical Chemistry, 50, 1344-1355.
http://dx.doi.org/10.1373/clinchem.2004.032227
[9] Bedossa, P., Dargère, D. and Paradis, V. (2003) Sampling Variability of Liver Fibrosis in Chronic Hepatitis C. Hepatology, 38, 1449-1457.
http://dx.doi.org/10.1016/j.hep.2003.09.022
[10] Piccinino, F., Sagnelli, E., Pasquale, G. and Giusti, G. (1986) Complications Following Percutaneous Liver Biopsy. A Multicentre Retrospective Study on 68,276 Biopsies. Journal of Hepatology, 2, 165-173.
[11] Perrault, J., McGill, D.B., Ott, B.J. and Taylor, W.F. (1978) Liver Biopsy: Complications in 1000 Inpatients and Outpatients. Gastroenterology, 74, 103-106.
[12] Imbert-Bismut, F., Ratziu, V., Pieroni, L., Charlotte, F., Benhamou, Y., Poynard, T. and Multivirc Group (2001) Biochemical Markers of Liver Fibrosis in Patients with Hepatitis C Virus Infection: A Prospective Study. The Lancet, 357, 1069-1075.
[13] Fontana, R.J., Goodman, Z.D., Dienstag, J.L., Bonkovsky, H.L., Naishadham, D., Sterling, R.K., Su, G.L., Ghosh, M., Wright, E.C. and HALT-C Trial Group (2008) Relationship of Serum Fibrosis Markers with Liver Fibrosis Stage and Collagen Content in Patients with Advanced Chronic Hepatitis C. Hepatology, 47, 789-798.
http://dx.doi.org/10.1002/hep.22099
[14] Sharma, S., Khalili, K. and Nguyen, G.C. (2014) Non-Invasive Diagnosis of Advanced Fibrosis and Cirrhosis. World Journal of Gastroenterology, 20, 16820-16830.
http://dx.doi.org/10.3748/wjg.v20.i45.16820
[15] Yonossi, Z., Lynn, G., Fang, Y., Srishord, M., Winter, P., Kallman, J. and Moon, J. (2012) Disparities in Activity Level and Mutrition between Patients with Chronic Hepatitic C and Blood Donors. The American of Physical Medicine and Rehabilitation, 4, 436-441.
[16] Dusheiko, G. and Westbrook, R.H. (2014) Natural History of Hepatitis C. Journal of Hepatology, 61, 558-568.
[17] White, D.L., Ratziu, V. and El-Serag, H.B. (2008) Hepatitis C Infection and Risk of Diabetes: A Systematic Review and Meta-Analysis. Journal of Hepatology, 49, 831-844.
http://dx.doi.org/10.1016/j.jhep.2008.08.006
[18] Mehta, S.H., Brancati, F.L., Strathdee, A.S., Pankow, J.S., Netski, D., Coresh, J., Szklo, M. and Thomas, D.L. (2003) Hepatitis C Virus Infection and Incident Type 2 Diabetes. Hepatology, 38, 50-56.
http://dx.doi.org/10.1053/jhep.2003.50291
[19] Delgado-Borrego, A., Liu, Y.S., Jordan, S.H., Agrawat, S., Zhang, H., Christofi, M., et al. (2008) Prospective Study of Liver Transplant Recipients with HCV Infection: Evidence for a Causal Relationship between HCV and Insulin Resistance. Liver Transplantation, 14, 183-201.
http://dx.doi.org/10.1002/lt.21267
[20] Fabrizi, F., Messa, P., Martin, P. and Takkouche, B. (2008) Hepatitis C Virus Infection and Post-Transplant Diabetes Mellitus among Renal Transplant Patients: A Meta-Analysis. International Journal of Artificial Organs, 31, 675-682.
[21] Shahid, M., Idrees, M., Nasir, B., Raja, A.J., Raza, S.M., Amin, I., Rasul, A. and Tayyab, G.U. (2014) Correlation of Biochemical Markers and HCV RNA Titers with Fibrosis Stages and Grades in Chronic HCV-3a Patients. European Journal of Gastroenterology & Hepatology, 26, 788-794.
http://dx.doi.org/10.1097/MEG.0000000000000109
[22] Shah, N.L., Northup, P.G. and Caldwell, S.H. (2015) Coagulation Abnormalities in Patients with Liver Disease. UPTODATE 18.0, February 2015.
[23] Lu, S.N., Wang, J.H., Liu, S.L., Hung, C.H., Chen, C.H., Tung, H.D., Chen, T.M., Huang, W.S., Lee, C.M., Chen, C.C. and Changchien, C.S. (2006) Thrombocytopenia as a Surrogate for Cirrhosis and a Marker for the Identification of Patients at High-Risk for Hepatocellular Carcinoma. Cancer, 107, 2212-2222.
http://dx.doi.org/10.1002/cncr.22242
[24] Kondo, R., Yano, H., Nakashima, O., Tanikawa, K., Nomura, Y. and Kage, M. (2013) Accumulation of Platelets in the Liver May Be an Important Contributory Factor to Thrombocytopenia and Liver Fibrosis in Chronic Hepatitis C. Journal of Gastroenterology, 48, 526-534.
http://dx.doi.org/10.1007/s00535-012-0656-2
[25] Lisman, T., Liebeek, F.W.G. and Groot, P.G. (2002) Haemostatic Abnormalities in Patients with Liver Disease. Journal of Hepatology, 37, 280-287.
http://dx.doi.org/10.1016/S0168-8278(02)00199-X
[26] Caldewell, S.H., Hoffman, M., Lisman, T., Marik, B.G., Northup, P.G., Reddy, K.R., et al. (2006) Coagulation Disorders and Hemostasis in Loiver Disease: Pathophysiology and Critical Assessment of Current Management. Hepatology, 44, 1039-1046.
http://dx.doi.org/10.1002/hep.21303
[27] Tripoli, A., Caldwell, S.H., Hoffman, M., Trotter, J.F. and Sanyal, A.J. (2007) Review Article: The Prothrombin Time Test as a Measure of Bleeding Risk and Prognosis in Liver Disease. Alimentary Pharmacology & Therapeutics, 26, 1418.
[28] Shet, S.G., Flamm, S.L., Gordon, F.D. and Choopra, S. (1998) AST/ALT Ratio Predicts Cirrhosis in Patients with Chronic Hepatitis C Virus Infection. American Journal of Gastroenterology, 93, 44-48.
http://dx.doi.org/10.1111/j.1572-0241.1998.044_c.x
[29] Golbberg, E. and Chopra, S. (2015) Cirrhosis in Adults: Etiologies, Clinical Manifestations, and Diagnosis. UPTODATE, 18.0, February 2015.
[30] Ghany, M.G., Lok, A.S., Ever-hart, J.E., Everson, G.T., Lee, W.M., Curto, T.M., Wright, E.C., Stoddard, A.M., Steling, R.K., Di Bisceglie, A.M., Bonkovsky, H.L., Morishima, C., Morgan, T.R. and Dientag, J.L., HALT-C Trial Group (2010) Predicting Clinical and Histologic Outcomes Based on Standard Laboratory Tests in Advanced Chronic Hepatitis C. Gastroenterology, 138, 136-146.
http://dx.doi.org/10.1053/j.gastro.2009.09.007

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.